Sep 30, 2018

Cogent Biosciences Q3 2018 Earnings Report

Total Revenue
$2.04M
Previous year: $2.33M
-12.4%
EPS
-$0.34
Previous year: -$0.946
-64.1%
Gross Profit
$2.04M
Previous year: $2.33M
-12.4%
Cash and Equivalents
$49.3M
Free Cash Flow
-$7.66M
Total Assets
$94.8M

Cogent Biosciences

Cogent Biosciences